Antisoma prepares its lead drug for commercialisation

Antisoma Plc said it is gearing up towards the regulatory filing and eventual commercialisation of its most advanced cancer product. Meanwhile, the UK company said its cash resources should fund all of its priority programmes until mid-2011.